These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23277171)
21. Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1. Lee JL; Kim JY; Ryu MH; Kang HJ; Chang HM; Kim TW; Lee H; Park JH; Kim HC; Kim JS; Kang YK Dig Dis Sci; 2006 Jun; 51(6):1043-6. PubMed ID: 16865565 [No Abstract] [Full Text] [Related]
22. Gastrointestinal stromal tumors. Antonescu C Curr Top Microbiol Immunol; 2012; 355():41-57. PubMed ID: 22015552 [TBL] [Abstract][Full Text] [Related]
23. Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature. Satzger I; Küttler U; Völker B; Schenck F; Kapp A; Gutzmer R Dermatology; 2010; 220(1):77-81. PubMed ID: 19996579 [TBL] [Abstract][Full Text] [Related]
24. [Consensus on the medical treatment of gastrointestinal stromal tumors]. Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652 [No Abstract] [Full Text] [Related]
25. A potential role for nilotinib in KIT-mutated melanoma. Tran A; Tawbi HA Expert Opin Investig Drugs; 2012 Jun; 21(6):861-9. PubMed ID: 22500535 [TBL] [Abstract][Full Text] [Related]
26. High CD133 expression levels in gastrointestinal stromal tumors. Bozzi F; Conca E; Manenti G; Negri T; Brich S; Gronchi A; Pierotti MA; Tamborini E; Pilotti S Cytometry B Clin Cytom; 2011; 80(4):238-47. PubMed ID: 21462307 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13. Bachet JB; Landi B; Laurent-Puig P; Italiano A; Le Cesne A; Lévy P; Safar V; Duffaud F; Blay JY; Emile JF Eur J Cancer; 2013 Jul; 49(11):2531-41. PubMed ID: 23648119 [TBL] [Abstract][Full Text] [Related]
28. [Clinical and molecular characterization of gastrointestinal stromal tumors (GIST)]. Mac K; Wójcik M Postepy Hig Med Dosw (Online); 2007 Jun; 62():272-81. PubMed ID: 18542042 [TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testing. Künstlinger H; Huss S; Merkelbach-Bruse S; Binot E; Kleine MA; Loeser H; Mittler J; Hartmann W; Hohenberger P; Reichardt P; Büttner R; Wardelmann E; Schildhaus HU Am J Surg Pathol; 2013 Nov; 37(11):1648-59. PubMed ID: 24061512 [TBL] [Abstract][Full Text] [Related]
30. Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT. Handolias D; Hamilton AL; Salemi R; Tan A; Moodie K; Kerr L; Dobrovic A; McArthur GA Br J Cancer; 2010 Apr; 102(8):1219-23. PubMed ID: 20372153 [TBL] [Abstract][Full Text] [Related]
31. c-KIT signaling as the driving oncogenic event in sub-groups of melanomas. Smalley KS; Sondak VK; Weber JS Histol Histopathol; 2009 May; 24(5):643-50. PubMed ID: 19283671 [TBL] [Abstract][Full Text] [Related]
32. High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors. Künstlinger H; Binot E; Merkelbach-Bruse S; Huss S; Wardelmann E; Buettner R; Schildhaus HU Hum Pathol; 2014 Mar; 45(3):573-82. PubMed ID: 24444465 [TBL] [Abstract][Full Text] [Related]
33. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor. Kleinbaum EP; Lazar AJ; Tamborini E; Mcauliffe JC; Sylvestre PB; Sunnenberg TD; Strong L; Chen LL; Choi H; Benjamin RS; Zhang W; Trent JC Int J Cancer; 2008 Feb; 122(3):711-8. PubMed ID: 17943734 [TBL] [Abstract][Full Text] [Related]
34. Predicting the antitumor effects of STI571 by analysis of c-kit gene mutations in gastrointestinal stromal tumors of the stomach: Report of a case. Tsuneoka N; Kuroki T; Haraguchi M; Furui J Surg Today; 2006; 36(11):989-93. PubMed ID: 17072721 [TBL] [Abstract][Full Text] [Related]
36. [Molecular and genetic features of gastrointestinal stromal tumors (GIST)]. Buleje S J; Yábar B A; Guevara-Fujita M; Fujita R Rev Gastroenterol Peru; 2012; 32(4):394-9. PubMed ID: 23307090 [TBL] [Abstract][Full Text] [Related]
37. Mutations in gastrointestinal stromal tumors diagnosed by endoscopic ultrasound-guided fine needle aspiration. Schmitt FC; Gomes AL; Milanezi F; Reis R; Bardales RH Minerva Med; 2007 Aug; 98(4):385-8. PubMed ID: 17921955 [TBL] [Abstract][Full Text] [Related]
38. Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendations. Blay JY; Reichardt P Expert Rev Anticancer Ther; 2009 Jun; 9(6):831-8. PubMed ID: 19496720 [TBL] [Abstract][Full Text] [Related]
39. [Activating mutations in receptor tyrosine kinases with relevance for treatment of gastrointestinal stromal tumors]. Wardelmann E; Merkelbach-Bruse S; Büttner R; Schildhaus HU Verh Dtsch Ges Pathol; 2007; 91():165-8. PubMed ID: 18314611 [TBL] [Abstract][Full Text] [Related]
40. Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma. Zukotynski K; Yap JT; Giobbie-Hurder A; Weber J; Gonzalez R; Gajewski TF; O'Day S; Kim K; Hodi FS; Van den Abbeele AD Cancer Imaging; 2014 Nov; 14(1):30. PubMed ID: 25609545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]